Target
Pteridine reductase 1
Ligand
BDBM50303509
Substrate
n/a
Meas. Tech.
ChEMBL_596055 (CHEMBL1037349)
Ki
>27000±n/a nM
Citation
 Tulloch, LBMartini, VPIulek, JHuggan, JKLee, JHGibson, CLSmith, TKSuckling, CJHunter, WN Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases. J Med Chem 53:221-9 (2010) [PubMed]  Article 
Target
Name:
Pteridine reductase 1
Synonyms:
HMTXR | PTR1 | PTR1_LEIMA
Type:
PROTEIN
Mol. Mass.:
30459.34
Organism:
Leishmania major
Description:
ChEMBL_1470027
Residue:
288
Sequence:
MTAPTVPVALVTGAAKRLGRSIAEGLHAEGYAVCLHYHRSAAEANALSATLNARRPNSAITVQADLSNVATAPVSGADGSAPVTLFTRCAELVAACYTHWGRCDVLVNNASSFYPTPLLRNDEDGHEPCVGDREAMETATADLFGSNAIAPYFLIKAFAHRFAGTPAKHRGTNYSIINMVDAMTNQPLLGYTIYTMAKGALEGLTRSAALELAPLQIRVNGVGPGLSVLVDDMPPAVWEGHRSKVPLYQRDSSAAEVSDVVIFLCSSKAKYITGTCVKVDGGYSLTRA
  
Inhibitor
Name:
BDBM50303509
Synonyms:
2-amino-6-bromo-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile | CHEMBL567352
Type:
Small organic molecule
Emp. Form.:
C7H4BrN5O
Mol. Mass.:
254.044
SMILES:
Nc1nc2[nH]c(Br)c(C#N)c2c(=O)[nH]1
Structure:
Search PDB for entries with ligand similarity: